Literature DB >> 33402089

Chemistry of Unsymmetrical C1-Substituted Oxabenzonorbornadienes.

Austin Pounder1, Angel Ho1, Matthew Macleod1, William Tam1.   

Abstract

Oxabenzonorbornadiene (OBD) is a useful synthetic intermediate which can be readily activated by transition metal complexes with great face selectivity due to its dual-faced nature and intrinsic angle strain on the alkene. To date, the understanding of transition-metal catalyzed reactions of OBD itself has burgeoned; however, this has not been the case for unsymmetrical OBDs. Throughout the development of these reactions, the nature of C1-substituent has proven to have a profound effect on both the reactivity and selectivity of the outcome of the reaction. Upon substitution, different modes of reactivity arise, contributing to the possibility of multiple stereo-, regio-, and in extreme cases, constitutional isomers which can provide unique means of constructing a variety of synthetically useful cyclic frameworks. To maximize selectivity, an understanding of bridgehead substituent effects is crucial. To that end, this review outlines hitherto reported examples of bridgehead substituent effects on the chemistry of unsymmetrical C1-substituted OBDs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Oxabenzonorbornadiene; cycloaddition; isomerization; regioselectivity.zzm321990; ring-opening; substituent effects; transition-metal-catalysis; unsymmetrical oxabenzonorbornadiene

Year:  2021        PMID: 33402089     DOI: 10.2174/1570179417666210105121115

Source DB:  PubMed          Journal:  Curr Org Synth        ISSN: 1570-1794            Impact factor:   1.975


  1 in total

1.  Iridium-catalyzed hydroacylation reactions of C1-substituted oxabenzonorbornadienes with salicylaldehyde: an experimental and computational study.

Authors:  Angel Ho; Austin Pounder; Krish Valluru; Leanne D Chen; William Tam
Journal:  Beilstein J Org Chem       Date:  2022-03-02       Impact factor: 2.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.